Why did Apollo Hospitals (APOLLOHOSP) stock move recently?

On 9/7/2026, Apollo Hospitals moved +1.3% — Rose as pharma and healthcare were the only major sectors to advance, with Nifty Pharma up about 0.75% while IT, metals and media dragged the benchmarks lower. The move tracked the defensive rotation rather than a company announcement. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is Apollo Hospitals (APOLLOHOSP) overvalued or fairly valued?

MarketChacha shows Apollo Hospitals's valuation in context — a forward P/E of about 40.2, a price-to-book of about 13.3 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Apollo Hospitals's revenue?

Apollo Hospitals reported revenue of ₹9,326 Cr for FY2026, with net profit of ₹1,493 Cr, per official filings.

What is the share price of Apollo Hospitals (APOLLOHOSP)?

Apollo Hospitals last traded at ₹8,768.50 (+0.8% on the day), as of 9/17/2026 — a delayed quote shown for education, not investment advice.

Apollo Hospitals

APOLLOHOSP · NSE · Healthcare · India

Snapshot

TickerAPOLLOHOSP

ExchangeNSE

SectorHealthcare

IndustryMedical Care Facilities

CountryIndia

Employees44,008

HeadquartersChennai, India

Websitewww.apollohospitals.com

Filings tracked5

About Apollo Hospitals

Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics, urology, organ transplantation, pulmonology, obstetrics and gynecology, internal medicine, vascular surgery, pediatrics, cosmetology, emergency medicine, bariatric surgery, general surgery, colorectal surgery, dentistry, nephrology, dermatology, endocrinology, preventive medicine, interventional radiology, ophthalmology, and integrative medicine, as well as robotic surgery and genomics. The company also provides project consultancy, medical educational institutes, Medvarsity for e-learning, and research services, as well as acts as an agent for life, general, and health insurance. In addition, it operates hospitals, pharmacies, primary care clinics, and diagnostic centers; short stay facilities, boutique birthing centers, multi-specialty clinics, dental and dialysis facilities, and preventive care; day surgery, diabetes management, and cradle and fertility centers; and Apollo 24/7, a digital health mobile platform that provides teleconsultations, online pharmacy deliveries, home diagnostics, and insurance services. Further, the company engages in the business of bio-banking of tissues. It serves patients, corporate clients, and the government and public sectors. Apollo Hospitals Enterprise Limited was incorporated in 1979 and is based in Chennai, India.

Who owns it

Promoters28.4%
Institutions50.5%
Public & other21.2%

305 institutional holders

Ownership breakdown from public market data. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Net margin trend4.9% → 7.7%

Margin has expanded by about 2.8 points — the business is getting more profitable.

Growth qualityrev 11% · PAT 24%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev ₹7,555 Cr · EPS 45.79

Est. earnings growth +27.4%

Next fiscal year

Rev ₹35,243 Cr · EPS 217.89

Est. earnings growth +26.8%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 4

Revenue (FY2026)

₹25,229 Cr

Net margin

7.7%

Revenue CAGR (3y)

+14.9%

Profit CAGR (3y)

+33.3%

Net profit (FY2026)

₹1,942 Cr

Ask MarketChacha about APOLLOHOSP

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Sep 7, 2026
Rose as pharma and healthcare were the only major sectors to advance, with Nifty Pharma up about 0.75% while IT, metals and media dragged the benchmarks lower. The move tracked the defensive rotation rather than a company announcement.
source 1 ↗source 2 ↗· confidence: medium
Aug 25, 2026
Apollo Hospitals Enterprise closed at Rs 8,889, among the top Nifty gainers, as the healthcare and pharma pack outperformed the broader index. The move reflected sector rotation into defensives rather than a company announcement.
source 1 ↗source 2 ↗· confidence: medium
Aug 14, 2026
Apollo Hospitals reported Q1 results with consolidated revenue up about 21% year-on-year to roughly Rs 7,043 crore, EBITDA up about 28% to Rs 1,092 crore and consolidated PAT up about 42% to about Rs 433 crore, with healthcare-services revenue helped by 11% volume growth. The stock closed near its day high and led the healthcare pack.
source 1 ↗source 2 ↗· confidence: high
Aug 12, 2026
Apollo Hospitals fell with the hospital sector after a Parliamentary Standing Committee recommended benchmarking private hospital room charges against three-star hotel tariffs and fixed package rates for standard procedures.
source 1 ↗· confidence: high
Aug 5, 2026
Apollo Hospitals slipped with the broader healthcare pack amid market softness and a continued overhang from proposed US tariffs on generic drugs; the Nifty Pharma index ended lower.
source 1 ↗source 2 ↗· confidence: medium

Daily moves with the verified reason behind them. Education only — not investment advice.

On MarketChacha

Posts about APOLLOHOSP

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹25,229 Cr	₹1,942 Cr	7.7%
FY2025	₹21,794 Cr	₹1,446 Cr	6.6%
FY2024	₹19,059 Cr	₹899 Cr	4.7%
FY2023	₹16,612 Cr	₹819 Cr	4.9%

Quarterly

Period	Revenue	Net profit	Net margin
Q4 FY26	₹6,606 Cr	₹529 Cr	8.0%
Q3 FY26	₹6,477 Cr	₹502 Cr	7.8%
Q2 FY26	₹6,304 Cr	₹477 Cr	7.6%
Q1 FY26	₹5,842 Cr	₹433 Cr	7.4%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

Filings & announcements

2026

Investor Presentation
As per annexure enclosed
BSE8/12/2026
Press Release / Media Release
As per annexure enclosec
BSE8/12/2026
Board Meeting Intimation for Notice Of The Board Meeting
Apollo Hospitals Enterprise Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve as per annexure enclosed
BSE7/16/2026material
Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting
as per annexure enclosed
BSE6/24/2026
Scheme of Arrangement
As per annexure enclosed
BSE6/24/2026

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.